SCHEMBL9033595

SCHEMBL9033595

CN(C)c1cc(C(=O)c2cccc(Cl)c2)c2ccccc2n1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCHR1 Q99705 2/20 0.48
ADRA2A P08913 1/20 0.48
S1PR1 P21453 1/20 0.45
OPRD1 P41143 1/20 0.45
MAOB P27338 1/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
HCRTR1 O43613 1/20 0.44
ALOX15 P16050 1/20 0.43
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
GFER P55789 1/20 0.43
ALDH1A1 P00352 5/20 0.42
KDM4E B2RXH2 4/20 0.42
GAA P10253 3/20 0.42
HPGD P15428 3/20 0.42
TSHR P16473 2/20 0.42
HSD17B10 Q99714 2/20 0.42
GLA P06280 2/20 0.41
MAPK1 P28482 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9033666 0.83 KDM4E (0.56) MEN1KMT2AALOX15NPC1RAB9A
SCHEMBL9034890 0.81 ALOX15 (0.46) MCHR1ADRA2AMAOBMEN1KMT2A
SCHEMBL9032661 0.80 MEN1 (0.51) MEN1KMT2AHCRTR1ALOX15NPC1
SCHEMBL16832665 0.78 KDM4E (0.57) S1PR1OPRD1MEN1KMT2ANPC1
SCHEMBL9033128 0.75 NPC1 (0.50) MAOBMEN1KMT2AALOX15NPC1
SCHEMBL28530337 0.73 KDM4E (0.53) S1PR1OPRD1MEN1KMT2ANPC1
SCHEMBL3446883 0.71 PARP1 (0.59) MAOBMEN1KMT2AALOX15NPC1
SCHEMBL28520672 0.70 ALOX15 (0.51) MEN1KMT2AALOX15NPC1RAB9A
SCHEMBL9034040 0.70 ADORA2A (0.46) S1PR1OPRD1MAOBALDH1A1KDM4E
SCHEMBL6457843 0.70 S1PR1 (0.52) S1PR1OPRD1MAOBMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5589484-A TREATMENT OF HELICOBACTER INFECTIONS, ANTIULCER JANSSEN PHARMACEUTICA N.V. (BE) 1996-12-31 US disclosed
EP-0666855-B1 4-QUINOLINYL DERIVATIVES WITH ANTI-HELICOBACTER ACTIVITY JANSSEN PHARMACEUTICA NV (BE) 1996-09-18 EP disclosed
EP-0666855-A1 4-QUINOLINYL DERIVATIVES WITH ANTI-HELICOBACTER ACTIVITY. JANSSEN PHARMACEUTICA NV (BE) 1995-08-16 EP disclosed
WO-1994010164-A1 4-QUINOLINYL DERIVATIVES WITH ANTI-HELICOBACTER ACTIVITY JANSSEN PHARMACEUTICA N.V. (BE) 1994-05-11 WO disclosed